E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/14/2016 in the Prospect News Bank Loan Daily.

S&P assigns Medical Depot loans B, CCC+ ratings

S&P said it assigned its B corporate credit rating to Medical Depot Holdings Inc. The outlook is stable.

At the same time, S&P assigned a B issue-level rating and a 3 recovery rating to Medical Depot's first-lien secured debt. The 3 recovery rating indicates expectations for meaningful (50%-70%, at the higher half of the range) recovery in the event of a default. S&P assigned a CCC+ issue-level rating and a 6 recovery rating to Medical Depot's second-lien secured debt. The 6 recovery rating indicates expectations for negligible (0%-10%) in a default.

CD&R Reign Merger Sub Inc. is the borrower of the debt.

“Medical Depot is a global manufacturer of generally very low-tech medical equipment, including durable medical products that support patient care primarily in the home setting,” said S&P’s Elan Nat. “Our assessment of business risk as vulnerable reflects the company's limited scale, low margins, and the limited barriers to entry in this fragmented and commodity-like product market.”


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.